Summary
In recent news, genetics testing giant, 23andMe, has informed several of its users about a security breach concerning its "DNA Relatives" feature. This feature, which enables users globally to compare and share ancestry data, was infiltrated, potentially exposing sensitive information like relationship labels, ancestry reports, matching DNA segments, and more.
Main information :
- The breach was discovered after a hacker boasted about stealing millions of data pieces from 23andMe on an online platform.
- 23andMe has been actively collaborating with federal law enforcement and forensic experts to delve deeper into the matter.
- The company has communicated to its users that unauthorized access was gained to certain accounts linked via the "DNA Relatives" feature.
- Post the revelation of this breach, there's been a surge in concerns among users about the potential misuse of their ethnicity and other sensitive data.
- 23andMe has temporarily disabled certain features in the "DNA Relatives" section to prioritize user privacy during this investigation.
FAQs
Our frequently questions
No items found.
Find out how iliomad can help your company.
[Map placeholder]
Only visible in production
Only visible in production
38.709099
-39.182035
1.6
6d17042a3425c5b3
October 9, 2026
Healthtech
Regulations & Guidelines
GDPR
Big Data
Health Data Strategy
AI passports and EHDS: what the CHAIN network means for health AI governance
The EU CHAIN network introduces AI Passports and federated health data models. Learn what this means for GDPR compliance, high-risk AI obligations and clinical sites.
October 8, 2026
Data Breach & Cybersecurity
Big Data
GDPR
Cybersecurity
Clinical Trials
Healthcare Data Breaches, AI Transparency and Clinical Research Standards: Weekly Digest
This week: Danish CPR breach, IQVIA Garante fine, OpenAI EU watermarking, Epic MyChart flaws, NIH funding decline and cancer trial QoL standards.
October 5, 2026
GDPR
Clinical Trials
Regulations & Guidelines
Cybersecurity
Vendor clinical trials: audit trails, logging gaps and sub-processor obligations
Understand vendor GDPR obligations in clinical trials, including audit-trail requirements, sub-processor controls and breach notification under Articles 28, 33 and 34.
